Articles with "alectinib refractory" as a keyword



Photo from wikipedia

Brigatinib in Patients With Alectinib‐Refractory ALK‐Positive NSCLC

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Thoracic Oncology"

DOI: 10.1016/j.jtho.2018.06.005

Abstract: Introduction: The second‐generation anaplastic lymphoma kinase (ALK) inhibitor alectinib recently showed superior efficacy compared to the first‐generation ALK inhibitor crizotinib in advanced ALK‐rearranged NSCLC, establishing alectinib as the new standard first‐line therapy. Brigatinib, another second‐generation… read more here.

Keywords: positive nsclc; alectinib refractory; alk; alk positive ... See more keywords